{
  "id": "sequoia:quince-therapeutics",
  "sequoia_id": "18474",
  "name": "Quince Therapeutics",
  "slug": "quince-therapeutics",
  "description": "Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patientâ€™s own biology for the treatment of rare diseases.",
  "website": "https://quincetx.com/",
  "socials": {},
  "categories": [
    "healthcare"
  ],
  "current_stage": "ipo",
  "first_partnered_year": 2018,
  "partners": [],
  "primary_partner": null,
  "milestones": {
    "founded_year": 2012,
    "partnered_year": 2018,
    "ipo_year": 2019,
    "acquired_year": null
  },
  "team": [],
  "why_partnered": null,
  "source_urls": {
    "directory": "https://sequoiacap.com/our-companies/",
    "profile": "https://sequoiacap.com/companies/quince-therapeutics/"
  }
}
